Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 45Colorectal Neoplasms 45Esophageal Neoplasms 28Esophageal Squamous Cell Carcinoma 24Stomach Neoplasms 22Pancreatic Neoplasms 19Colonic Neoplasms 18Adenocarcinoma Of Esophagus 15Carcinoma, Hepatocellular 14Neoplasm Metastasis 7Liver Neoplasms 6Cholangiocarcinoma 5Recurrence 4Locally Advanced Rectal Cancer 4Turcot syndrome 3Peritoneal Neoplasms 2Neoplasms 2Gastrointestinal Stromal Tumors 2Breast Neoplasms 2Bites and Stings 2Adenocarcinoma 2Surgery 1Successful Conversion Rate of Operation 1Radiation Injuries 1QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy 1Peritoneal Metastases From Gastric Cancer 1Peritoneal Metastases From Colorectal Cancer 1Pathologic Complete Response 1Pancreatic Ductal Adenocarcinoma (PDAC) 1Pancreatic Ductal Adenocarcinoma 1

Interventions

pembrolizumab 7Nivolumab 3fludarabine 2durvalumab 2avelumab 2atezolizumab 2Cyclophosphamide 2tremelimumab 1fludarabine phosphate 1epacadostat 1bintrafusp alfa protein, human 1aldesleukin 1Therapeutics 1Temozolomide 1Surgical Procedures, Operative 1Specimen Handling 1Oxaliplatin 1Neoadjuvant Therapy 1Ipilimumab 1Interleukin-2 1Injections 1High-Throughput Nucleotide Sequencing 1Educational Status 1Drug Therapy 1Docetaxel 1Chemotherapy, Adjuvant 1Carboxylesterase 1Capecitabine 1Bevacizumab 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Microsatellite Instability × Neoadjuvant Therapy × Gastrointestinal × Clear all
NCT03519412 2026-03-03

ARETHUSA

IFOM ETS - The AIRC Institute of Molecular Oncology

Phase 2 Completed
107 enrolled 14 charts
Gastrointestinal

Colorectal Neoplasms, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡